[1. Dragomir AD, Schroeder JC, Connolly A, et al. Potential risk factors associated with subtypes of uterine leiomyomata. Reprod Sci. 2010;17:1029.10.1177/1933719110376979]Search in Google Scholar
[2. Enkatachalam S, Bagratee JS, Moodley J. Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study. J Obstet Gynaecol. 2004;24:798.10.1080/01443610400009543]Search in Google Scholar
[3. Parazzini F, Negri E, La Vecchia C, et al. Uterine myomas and smoking. Results from an Italian study. J Reprod Med. 1996;41:316.]Search in Google Scholar
[4. Chiaffarino, F, Parazzini, F, La Vecchia, C, et al. Diet and uterine myomas. Obstet Gynecol. 1999;94:395.]Search in Google Scholar
[5. Wise LA, Palmer JR, Harlow BL, et al. Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women’s Health Study. Hum Reprod. 2004;19:1746.10.1093/humrep/deh309]Search in Google Scholar
[6. Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate?. Hum Reprod. 2002;17:1424.10.1093/humrep/17.6.1424]Search in Google Scholar
[7. Marshall LM, Spiegelman D, Barbieri RL et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol. 1997;90:967.10.1016/S0029-7844(97)00534-6]Search in Google Scholar
[8. Yoshida M, Koshiyama M, Fujii H, Konishi M. Erythrocytosis and a fibroid. Lancet. 1999;354:216.10.1016/S0140-6736(99)02273-4]Search in Google Scholar
[9. Syrop CH, Nygaard IE, Davis WA. Natural history of uterine polyps and leiomyomata. Obstet Gynecol. 2002;100:3.]Search in Google Scholar
[10. Viswanathan M, Hartmann K, McKoy N, et al. Management of uterine fibroids: an update of the evidence. Evid Rep Technol Assess (Full Rep); 2007.]Search in Google Scholar
[11. Minaguchi H, Wong JM, Snabes MC. Clinical use of nafarelin in the treatment of leiomyomas. A review of the literature. J Reprod Med. 2000;45:481.]Search in Google Scholar
[12. Eisinger SH, Meldrum S, Fiscella K, et al. Low-dose mifepristone for uterine leiomyomata. Obstet Gynecol. 2003;101:243.]Search in Google Scholar
[13. Hanafi M. Recurrence after removal of solitary and multiple myomas. Obstet Gynecol. 2005;105:877.10.1097/01.AOG.0000156298.74317.62]Search in Google Scholar
[14. Hald K, Langebrekke A, Klow NE, et al. Laparoscopic occlusion of uterine vessels for the treatment of symptomatic fibroids: Initial experience and comparison to uterine artery embolization. Am J Obstet Gynecol. 2004;190:37.10.1016/S0002-9378(03)00910-4]Search in Google Scholar
[15. DeCherney AH, Nathan L. Current obstetric & gynecologic diagnosis & treatment. 9th ed. New York (NY): Lange Medical/McGraw-Hill; 2003. p. 708-715.]Search in Google Scholar
[16. Vladimír B, Peter K, Robert F. Giant Uterine Leiomyoma in a Young Woman as an Incidental Finding After a Car Accident: A Case Report. Acta Medica (Hradec Králové) 2018;61(1):29-32.]Search in Google Scholar
[17. Novi JM, Shaunik A, Mulvihill BH, Morgan MA. Acute urinary retention caused by a uterine leiomyoma: a case report, J Reprod Med. 2004;49:131-132.]Search in Google Scholar
[18. Ozsaran AA, Itil IM, Terek C, Kazandi M, Dikmen Y. Giant myoma and erythrocytosis syndrome, Aust N Z J Obstet Gynaecol. 1999;39:384-386.]Search in Google Scholar